Brett Smith for redOrbit.com - Your Universe Online People with depression who have tried many different treatments without success may have one more option in the near future: laughing gas. According to new research published in the journal...
Latest placebo Stories
MILAN, December 19, 2014 /PRNewswire/ -- - First New Chemical Entity (NCE) in 10 years to receive a positive opinion from CHMP for the treatment
HELSINKI, December 18, 2014 /PRNewswire/ -- Placebo-Controlled, Double-Blind Field Study on Jet Lag Treatment Followed by Development of New Smartphone
Study Met All Primary Endpoints Against Stelara® (ustekinumab) and Placebo THOUSAND OAKS, Calif. and LONDON, Nov.
Randomized Controlled Trial Conducted at the Santa Casa de Sao Paulo School of Medicine in Brazil LOS ANGELES, Nov.
Phase II Results Unveiled at 2014 American College of Rheumatology Annual Meeting TUSCALOOSA, Ala. and BOSTON, Nov.
Depression Biomarker Analysis Shows NSI-189 is Rapidly and Persistently Efficacious GERMANTOWN, Md., Nov. 17, 2014 /PRNewswire/ -- Neuralstem, Inc.
LOS ANGELES, Nov. 17, 2014 /PRNewswire/ -- NeuroSigma®, Inc.
- Secukinumab met primary endpoints demonstrating statistically significant improvements versus placebo in signs and symptoms of active psoriatic arthritis (PsA) in two pivotal Phase III studies
- Secukinumab is the first selective IL-17A inhibitor to significantly improve signs and symptoms of ankylosing spondylitis (AS) versus placebo in Phase III studies EAST HANOVER, N.J., Nov.
ENGLEWOOD, Colo., Nov. 12, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.
- A transitional zone between two communities containing the characteristic species of each.